Upcoming FDA actions could impact multiple treatment landscapes. MPR highlights key decisions to watch for in October and the clinical implications for practice. #FDADecisions #DrugsInThePipeline https://www.empr.com/news/october-2026-fda-pdufa-dates/
FDA Drug Approval Decisions Expected in October 2026
A closer look at five anticipated FDA approval decisions in October 2026 spanning oncology, infectious diseases, and ophthalmology.
www.empr.com
September 3, 2026 at 8:58 PM
Upcoming FDA actions could impact multiple treatment landscapes. MPR highlights key decisions to watch for in October and the clinical implications for practice. #FDADecisions #DrugsInThePipeline https://www.empr.com/news/october-2026-fda-pdufa-dates/
Picking Apart the Destructive Claim That Industry Controls FDA. Examines the revolving door, DOGE RIF’s, and the way FDA makes product decisions. Analysis, not news coverage.
www.fdamatters.com/fdamatters/p...
#FDA #FDAMatters #RevolvingDoor #FDADecisions #RIF #DOGE #IndustryControlofFDA
www.fdamatters.com/fdamatters/p...
#FDA #FDAMatters #RevolvingDoor #FDADecisions #RIF #DOGE #IndustryControlofFDA
Picking Apart the Destructive Claim That Industry Controls FDA — FDA Matters
I am tired of the continued defamation of FDA as an agency controlled by industry. That is not to say that FDA is perfect or that there have never been FDA-industry interactions that looked (an...
www.fdamatters.com
May 12, 2025 at 2:51 PM
Picking Apart the Destructive Claim That Industry Controls FDA. Examines the revolving door, DOGE RIF’s, and the way FDA makes product decisions. Analysis, not news coverage.
www.fdamatters.com/fdamatters/p...
#FDA #FDAMatters #RevolvingDoor #FDADecisions #RIF #DOGE #IndustryControlofFDA
www.fdamatters.com/fdamatters/p...
#FDA #FDAMatters #RevolvingDoor #FDADecisions #RIF #DOGE #IndustryControlofFDA